Lypoatrophy (loss of subcutaneous fat) usually caused by HIV+ treatments

Our treatments address the effects of HIV+ therapy by reducing the look of lipoatrophy (loss of fat) in the skin which is highly visible in the face of patients.
What is Type A
It is a permanent dermal filler, mostly water: 97.5% and 2.5% non-animal Polyacrylamide Gel, making it a toxic stable and non-resorable gel that is highly bio compatible.
Is it safe?
More than 300,000 people have been successfully treated in more than 40 countries around the world. We have successfully completed over 200 treatments.
What is the treatment like?
Tiny injections along the depressions of the skin are corrected by filling with our product. After injection, the gel binds water and generally remains in the skin for many years puffing out the skin and reducing the look of Lipoatrophy.
What results can I expect?
Results are immediate. The skin will be ‘plumped up’ dramatically improving the appearance of the skin. We find that confidence is restored and also removes the stigmatisms associated with HIV+ treatments.

page 2